5 quarters tracked · Beat rate 60% · Updated quarterly
| Period | Report Date | EPS Estimate | EPS Actual | Surprise | Result |
|---|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $2.94 | $2.99 | +1.8% | Beat |
| Q1 2026 | 2026-03-31 | $3.40 | $3.36 | -1.2% | Miss |
| Q4 2025 | 2025-12-31 | $2.77 | $2.77 | -0.0% | Miss |
| Q3 2025 | 2025-09-30 | $2.66 | $2.68 | +0.8% | Beat |
| Q2 2025 | 2025-06-30 | $2.95 | $2.96 | +0.4% | Beat |
Earnings Beat Rate
CME Group has beaten analyst EPS estimates in 3 of 5 tracked quarters (60% beat rate). Data sourced from SEC filings and analyst consensus. View full AI analysis →